The involvement of microRNAs in malignant transformation

Histology and Histopathology

Volumn 27, Issue 10, 2012, Pages 1263-1270

  Rutnam, Zina Jeyapalan ^a,b   Yang, Burton B ^a,b  

^a Sunnybrook Health Sciences Centre   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; Cancer progression; Cancer stem cells; Oncogenic miRNA

Indexed keywords

DIAGNOSTIC AGENT; MICRORNA; RNA; UNTRANSLATED RNA;

BREAST TUMOR; CANCER STEM CELL; CELL TRANSFORMATION; DISEASE COURSE; FEMALE; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW;

BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FEMALE; HUMANS; MICRORNAS; NEOPLASMS; NEOPLASTIC STEM CELLS; RNA, NEOPLASM; RNA, UNTRANSLATED;

EID: 84867537443     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Agirre X., Vilas-Zornoza A., Jimenez-Velasco A., Martin-Subero J.I., Cordeu L., Garate L., San Jose-Eneriz E., Abizanda G., Rodriguez-Otero P., Fortes P., Rifon J., Bandres E., Calasanz M.J., Martin V., Heiniger A., Torres A., Siebert R., Roman-Gomez J. and Prosper F. (2009). Epigenetic silencing of the tumor suppressor microRNA hsamiR-124a regulates cdk6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res. 69, 4443-4453.
2. Al-Hajj M., Becker M.W., Wicha M., Weissman I. and Clarke M.F. (2004). Therapeutic implications of cancer stem cells. Curr. Opin. Genet. Dev. 14, 43-47.
3. Ando T., Yoshida T., Enomoto S., Asada K., Tatematsu M., Ichinose M., Sugiyama T. and Ushijima T. (2009). DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: Its possible involvement in the formation of epigenetic field defect. Int. J. Cancer 124, 2367-2374.
4. Asangani I.A., Rasheed S.A., Nikolova D.A., Leupold J.H., Colburn N.H., Post S. and Allgayer H. (2008). Microrna-21 (miR-21) posttranscriptionally downregulates tumor suppressor pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128-2136.
5. Bartel D.P. (2004). Micrornas: Genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
6. Bartel D.P. (2009). Micrornas: Target recognition and regulatory functions. Cell 136, 215-233.
7. Berezikov E., Guryev V., van de Belt J., Wienholds E., Plasterk R.H. and Cuppen E. (2005). Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120, 21-24.
8. Bonci D. (2010). Microrna-21 as therapeutic target in cancer and cardiovascular disease. Recent Pat. Cardiovasc. Drug Discov. 5, 156-161.
9. Bueno M.J., Perez de Castro I., Gomez de Cedron M., Santos J., Calin G.A., Cigudosa J.C., Croce C.M., Fernandez-Piqueras J. and Malumbres M. (2008). Genetic and epigenetic silencing of microRNA-203 enhances abl1 and bcr-abl1 oncogene expression. Cancer Cell 13, 496-506.
10. Cairo S., Wang Y., de Reynies A., Duroure K., Dahan J., Redon M.J., Fabre M., McClelland M., Wang X.W., Croce C.M. and Buendia M.A. (2010). Stem cell-like micro-rna signature driven by myc in aggressive liver cancer. Proc. Natl. Acad. Sci. USA 107, 20471-20476.
11. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M. and Croce C.M. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 101, 2999-3004.
12. Cao X., Pfaff S.L. and Gage F.H. (2007). A functional study of miR-124 in the developing neural tube. Genes Dev. 21, 531-536.
13. Chan J.A., Krichevsky A.M. and Kosik K.S. (2005). Microrna-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65, 6029-6033.
14. Collins R.E. and Cheng X. (2005). Structural domains in rnai. FEBS Lett. 579, 5841-5849.
15. Connolly E., Melegari M., Landgraf P., Tchaikovskaya T., Tennant B.C., Slagle B.L., Rogler L.E., Zavolan M., Tuschl T. and Rogler C.E. (2008). Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am. J. Pathol. 173, 856-864.
16. Corsten M.F., Miranda R., Kasmieh R., Krichevsky A.M., Weissleder R. and Shah K. (2007). Microrna-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered s-trail in human gliomas. Cancer Res. 67, 8994-9000.
17. Dalmay T. and Edwards D.R. (2006). Micrornas and the hallmarks of cancer. Oncogene 25, 6170-6175.
18. Ebert M.S., Neilson J.R. and Sharp P.A. (2007). Microrna sponges: Competitive inhibitors of small rnas in mammalian cells. Nat. Methods 4, 721-726.
19. Esquela-Kerscher A., Trang P., Wiggins J.F., Patrawala L., Cheng A., Ford L., Weidhaas J.B., Brown D., Bader A.G. and Slack F.J. (2008). The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 7, 759-764.
20. Fang L., Deng Z., Shatseva T., Yang J., Peng C., Du W.W., Yee A.J., Ang L.C., He C., Shan S.W. and Yang B.B. (2011). Microrna miR-93 promotes tumor growth and angiogenesis by targeting integrinbeta8. Oncogene 30, 806-821.
21. Fasbender A., Lee J.H., Walters R.W., Moninger T.O., Zabner J. and Welsh M.J. (1998). Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo. J. Clin. Invest. 102, 184-193.
22. Foekens J.A., Sieuwerts A.M., Smid M., Look M.P., de Weerd V., Boersma A.W., Klijn J.G., Wiemer E.A. and Martens J.W. (2008). Four miRNAs associated with aggressiveness of lymph nodenegative, estrogen receptor-positive human breast cancer. Proc. Natl. Acad. Sci. USA 105, 13021-13026.
23. Fujita S., Ito T., Mizutani T., Minoguchi S., Yamamichi N., Sakurai K. and Iba H. (2008). Mir-21 gene expression triggered by ap-1 is sustained through a double-negative feedback mechanism. J. Mol. Biol. 378, 492-504.
24. Furuta M., Kozaki K.I., Tanaka S., Arii S., Imoto I. and Inazawa J. (2010). Mir-124 and miR-203 are epigenetically silenced tumorsuppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31, 766-776.
25. Garofalo M., Quintavalle C., Romano G., Croce C.M. and Condorelli G. (2012). Mir221/222 in cancer: Their role in tumor progression and response to therapy. Curr. Mol. Med. 12, 27-33.
26. Gentner B., Schira G., Giustacchini A., Amendola M., Brown B.D., Ponzoni M. and Naldini L. (2009). Stable knockdown of microRNA in vivo by lentiviral vectors. Nat. Methods 6, 63-66.
27. Godlewski J., Nowicki M.O., Bronisz A., Williams S., Otsuki A., Nuovo G., Raychaudhury A., Newton H.B., Chiocca E.A. and Lawler S. (2008). Targeting of the bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 68, 9125-9130.
28. Hackanson B., Bennett K.L., Brena R.M., Jiang J., Claus R., Chen S.S., Blagitko-Dorfs N., Maharry K., Whitman S.P., Schmittgen T.D., Lubbert M., Marcucci G., Bloomfield C.D. and Plass C. (2008). Epigenetic modification of ccaat/enhancer binding protein alpha expression in acute myeloid leukemia. Cancer Res. 68, 3142-3151.
29. Haraguchi T., Ozaki Y. and Iba H. (2009). Vectors expressing efficient rna decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res. 37, e43.
30. Hatfield S. and Ruohola-Baker H. (2008). Microrna and stem cell function. Cell Tissue Res. 331, 57-66.
31. Hausler S.F., Keller A., Chandran P.A., Ziegler K., Zipp K., Heuer S., Krockenberger M., Engel J.B., Honig A., Scheffler M., Dietl J. and Wischhusen J. (2010). Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br. J. Cancer 103, 693-700.
32. Hill D.A., Ivanovich J., Priest J.R., Gurnett C.A., Dehner L.P., Desruisseau D., Jarzembowski J.A., Wikenheiser-Brokamp K.A., Suarez B.K., Whelan A.J., Williams G., Bracamontes D., Messinger Y. and Goodfellow P.J. (2009). Dicer1 mutations in familial pleuropulmonary blastoma. Science 325, 965.
33. Hua Z., Lv Q., Ye W., Wong C.K., Cai G., Gu D., Ji Y., Zhao C., Wang J., Yang B.B. and Zhang Y. (2006). Mirna-directed regulation of vegf and other angiogenic factors under hypoxia. PLoS One 1, e116.
34. Huang Z., Huang D., Ni S., Peng Z., Sheng W. and Du X. (2010). Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 127, 118-126.
35. Hutvagner G., Simard M.J., Mello C.C. and Zamore P.D. (2004). Sequence-specific inhibition of small rna function. PLoS Biol. 2, E98.
36. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., Menard S., Palazzo J.P., Rosenberg A., Musiani P., Volinia S., Nenci I., Calin G.A., Querzoli P., Negrini M. and Croce C.M. (2005). Microrna gene expression deregulation in human breast cancer. Cancer Res. 65, 7065-7070.
37. Jeyapalan Z. and Yang B.B. (2012). The non-coding 3'utr of cd44 induces metastasis by regulating extracellular matrix functions. J. Cell. Sci.
38. Jeyapalan Z., Deng Z., Shatseva T., Fang L., He C. and Yang B.B. (2011). Expression of cd44 3'-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis. Nucleic Acids Res. 39, 3026-3041.
39. Ji Q., Hao X., Meng Y., Zhang M., Desano J., Fan D. and Xu L. (2008). Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 8, 266.
40. Ji Q., Hao X., Zhang M., Tang W., Yang M., Li L., Xiang D., Desano J.T., Bommer G.T., Fan D., Fearon E.R., Lawrence T.S. and Xu L. (2009). Microrna miR-34 inhibits human pancreatic cancer tumorinitiating cells. PLoS One 4, e6816.
41. Jiang S., Zhang H.W., Lu M.H., He X.H., Li Y., Gu H., Liu M.F. and Wang E.D. (2010). Microrna-155 functions as an oncomir in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res. 70, 3119-3127.
42. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K.L., Brown D. and Slack F.J. (2005). Ras is regulated by the let-7 microRNA family. Cell 120, 635-647.
43. Kahai S., Lee S.C., Lee D.Y., Yang J., Li M., Wang C.H., Jiang Z., Zhang Y., Peng C. and Yang B.B. (2009). Microrna miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting galnt-7. PLoS One 4, e7535.
44. Kang J.G., Majerciak V., Uldrick T.S., Wang X., Kruhlak M., Yarchoan R. and Zheng Z.M. (2011). Kaposi's sarcoma-associated herpesviral il-6 and human il-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation. J. Pathol. 225, 378-389.
45. Kozaki K., Imoto I., Mogi S., Omura K. and Inazawa J. (2008). Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 68, 2094-2105.
46. Krichevsky A.M. and Gabriely G. (2009). Mir-21: A small multi-faceted rna. J. Cell. Mol. Med. 13, 39-53.
47. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M. and Stoffel M. (2005). Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689.
48. Latronico M.V., Catalucci D. and Condorelli G. (2007). Emerging role of microRNAs in cardiovascular biology. Circ. Res. 101, 1225-1236.
49. Lee Y., Hur I., Park S.Y., Kim Y.K., Suh M.R. and Kim V.N. (2006). The role of pact in the rna silencing pathway. EMBO J. 25, 522-532.
50. Lee D.Y., Deng Z., Wang C.H. and Yang B.B. (2007). Microrna-378 promotes cell survival, tumor growth, and angiogenesis by targeting sufu and fus-1 expression. Proc. Natl. Acad. Sci. USA 104, 20350-20355.
51. Lee E.J., Baek M., Gusev Y., Brackett D.J., Nuovo G.J. and Schmittgen T.D. (2008). Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA 14, 35-42.
52. Lee D.Y., Shatseva T., Jeyapalan Z., Du W.W., Deng Z. and Yang B.B. (2009). A 3'-untranslated region (3'utr) induces organ adhesion by regulating miR-199a* functions. PLoS One 4, e4527.
53. Lee D.Y., Jeyapalan Z., Fang L., Yang J., Zhang Y., Yee A.Y., Li M., Du W.W., Shatseva T. and Yang B.B. (2010). Expression of versican 3'-untranslated region modulates endogenous microRNA functions. PLoS One 5, e13599.
54. Lee S.C., Fang L., Wang C.H., Kahai S., Deng Z. and Yang B.B. (2011). A non-coding transcript of nephronectin promotes osteoblast differentiation by modulating microRNA functions. FEBS Lett. 585, 2610-2616.
55. Lewis B.P., Burge C.B. and Bartel D.P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
56. Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., Bartel D.P., Linsley P.S. and Johnson J.M. (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mrnas. Nature 433, 769-773.
57. Liu C., Kelnar K., Liu B., Chen X., Calhoun-Davis T., Li H., Patrawala L., Yan H., Jeter C., Honorio S., Wiggins J.F., Bader A.G., Fagin R., Brown D. and Tang D.G. (2011). The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing cd44. Nat. Med. 17, 211-215.
58. Liu J., Valencia-Sanchez M.A., Hannon G.J. and Parker R. (2005). Microrna-dependent localization of targeted mrnas to mammalian pbodies. Nat. Cell Biol. 7, 719-723.
59. Lowery A.J., Miller N., Devaney A., McNeill R.E., Davoren P.A., Lemetre C., Benes V., Schmidt S., Blake J., Ball G. and Kerin M.J. (2009). Microrna signatures predict oestrogen receptor, progesterone receptor and her2/neu receptor status in breast cancer. Breast Cancer Res. 11, R27.
60. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R. and Golub T.R. (2005). Microrna expression profiles classify human cancers. Nature 435, 834-838.
61. Lujambio A., Ropero S., Ballestar E., Fraga M.F., Cerrato C., Setien F., Casado S., Suarez-Gauthier A., Sanchez-Cespedes M., Git A., Spiteri I., Das P.P., Caldas C., Miska E. and Esteller M. (2007). Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 67, 1424-1429.
62. Luo L., Ye G., Nadeem L., Fu G., Yang B.B., Dunk C., Lye S. and Peng C. (2012). Microrna-378a-5p promotes trophoblast cell survival, migration and invasion by targeting nodal. J. Cell Sci. (in press).
63. Ma L., Teruya-Feldstein J. and Weinberg R.A. (2007). Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688.
64. Ma L., Young J., Prabhala H., Pan E., Mestdagh P., Muth D., Teruya-Feldstein J., Reinhardt F., Onder T.T., Valastyan S., Westermann F., Speleman F., Vandesompele J. and Weinberg R.A. (2010). Mir-9, a myc/mycn-activated microRNA, regulates e-cadherin and cancer metastasis. Nat. Cell Biol. 12, 247-256.
65. Mayr C., Hemann M.T. and Bartel D.P. (2007). Disrupting the pairing between let-7 and hmga2 enhances oncogenic transformation. Science 315, 1576-1579.
66. McPherson J.P., Tamblyn L., Elia A., Migon E., Shehabeldin A., Matysiak-Zablocki E., Lemmers B., Salmena L., Hakem A., Fish J., Kassam F., Squire J., Bruneau B.G., Hande M.P. and Hakem R. (2004). Lats2/kpm is required for embryonic development, proliferation control and genomic integrity. EMBO J. 23, 3677-3688.
67. Meister G., Landthaler M., Dorsett Y. and Tuschl T. (2004). Sequencespecific inhibition of microRNA-and sirna-induced rna silencing. RNA 10, 544-550.
68. Melo S.A., Ropero S., Moutinho C., Aaltonen L.A., Yamamoto H., Calin G.A., Rossi S., Fernandez A.F., Carneiro F., Oliveira C., Ferreira B., Liu C.G., Villanueva A., Capella G., Schwartz S. Jr., Shiekhattar R. and Esteller M. (2009). A tarbp2 mutation in human cancer impairs microRNA processing and dicer1 function. Nat. Genet. 41, 365-370.
69. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T. and Patel T. (2007). Microrna-21 regulates expression of the pten tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647-658.
70. Merritt W.M., Lin Y.G., Han L.Y., Kamat A.A., Spannuth W.A., Schmandt R., Urbauer D., Pennacchio L.A., Cheng J.F., Nick A.M., Deavers M.T., Mourad-Zeidan A., Wang H., Mueller P., Lenburg M.E., Gray J.W., Mok S., Birrer M.J., Lopez-Berestein G., Coleman R.L., Bar-Eli M. and Sood A.K. (2008). Dicer, drosha, and outcomes in patients with ovarian cancer. N. Engl. J. Med. 359, 2641-2650.
71. Michael M.Z., SM O.C., van Holst Pellekaan N.G., Young G.P. and James R.J. (2003). Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 1, 882-891.
72. Olson P., Lu J., Zhang H., Shai A., Chun M.G., Wang Y., Libutti S.K., Nakakura E.K., Golub T.R. and Hanahan D. (2009). Microrna dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev. 23, 2152-2165.
73. Orom U.A., Kauppinen S. and Lund A.H. (2006). Lna-modified oligonucleotides mediate specific inhibition of microRNA function. Gene 372, 137-141.
74. Poliseno L., Salmena L., Zhang J., Carver B., Haveman W.J. and Pandolfi P.P. (2010). A coding-independent function of gene and pseudogene mrnas regulates tumour biology. Nature 465, 1033-1038.
75. Racz Z., Kaucsar T. and Hamar P. (2011). The huge world of small rnas: Regulating networks of microRNAs (review). Acta Physiol. Hung. 98, 243-251.
76. Radojicic J., Zaravinos A., Vrekoussis T., Kafousi M., Spandidos D.A. and Stathopoulos E.N. (2011). Microrna expression analysis in triple-negative (ER, PR and HER2/neu) breast cancer. Cell Cycle 10, 507-517.
77. Rao X., Di Leva G., Li M., Fang F., Devlin C., Hartman-Frey C., Burow M.E., Ivan M., Croce C.M. and Nephew K.P. (2011). Microrna-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene 30, 1082-1097.
78. Roman-Gomez J., Agirre X., Jimenez-Velasco A., Arqueros V., Vilas-Zornoza A., Rodriguez-Otero P., Martin-Subero I., Garate L., Cordeu L., San Jose-Eneriz E., Martin V., Castillejo J.A., Bandres E., Calasanz M.J., Siebert R., Heiniger A., Torres A. and Prosper F. (2009). Epigenetic regulation of microRNAs in acute lymphoblastic leukemia. J. Clin. Oncol. 27, 1316-1322.
79. Ruvkun G. (2006). Clarifications on miRNA and cancer. Science 311, 36-37.
80. Sachdeva M. and Mo Y.Y. (2010). Microrna-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res. 70, 378-387.
81. Sampson V.B., Rong N.H., Han J., Yang Q., Aris V., Soteropoulos P., Petrelli N.J., Dunn S.P. and Krueger L.J. (2007). Microrna let-7a down-regulates myc and reverts myc-induced growth in burkitt lymphoma cells. Cancer Res. 67, 9762-9770.
82. Shimono Y., Zabala M., Cho R.W., Lobo N., Dalerba P., Qian D., Diehn M., Liu H., Panula S.P., Chiao E., Dirbas F.M., Somlo G., Pera R.A., Lao K. and Clarke M.F. (2009). Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592-603.
83. Si M.L., Zhu S., Wu H., Lu Z., Wu F. and Mo Y.Y. (2007). Mir-21-mediated tumor growth. Oncogene 26, 2799-2803.
84. Silber J., Lim D.A., Petritsch C., Persson A.I., Maunakea A.K., Yu M., Vandenberg S.R., Ginzinger D.G., James C.D., Costello J.F., Bergers G., Weiss W.A., Alvarez-Buylla A. and Hodgson J.G. (2008). Mir-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 6, 14.
85. Soutschek J., Akinc A., Bramlage B., Charisse K., Constien R., Donoghue M., Elbashir S., Geick A., Hadwiger P., Harborth J., John M., Kesavan V., Lavine G., Pandey R.K., Racie T., Rajeev K.G., Rohl I., Toudjarska I., Wang G., Wuschko S., Bumcrot D., Koteliansky V., Limmer S., Manoharan M. and Vornlocher H.P. (2004). Therapeutic silencing of an endogenous gene by systemic administration of modified sirnas. Nature 432, 173-178.
86. Spizzo R., Nicoloso M.S., Lupini L., Lu Y., Fogarty J., Rossi S., Zagatti B., Fabbri M., Veronese A., Liu X., Davuluri R., Croce C.M., Mills G., Negrini M. and Calin G.A. (2010). Mir-145 participates with tp53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ. 17, 246-254.
87. Swami M. (2010). Small rnas: Pseudogenes act as microRNA decoys. Nat. Rev. Cancer 10, 535.
88. Tavazoie S.F., Alarcon C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L. and Massague J. (2008). Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147-152.
89. Vasudevan S., Tong Y. and Steitz J.A. (2007). Switching from repression to activation: Micrornas can up-regulate translation. Science 318, 1931-1934.
90. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C. and Croce C.M. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103, 2257-2261.
91. Wang C.H., Lee D.Y., Deng Z., Jeyapalan Z., Lee S.C., Kahai S., Lu W.Y., Zhang Y. and Yang B.B. (2008). Microrna miR-328 regulates zonation morphogenesis by targeting cd44 expression. PLoS One 3, e2420.
92. Wang S., Wang L., Zhu T., Gao X., Li J., Wu Y. and Zhu H. (2010). Improvement of tissue preparation for laser capture microdissection: Application for cell type-specific miRNA expression profiling in colorectal tumors. BMC Genomics 11, 163.
93. Wickramasinghe N.S., Manavalan T.T., Dougherty S.M., Riggs K.A., Li Y. and Klinge C.M. (2009). Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in mcf-7 breast cancer cells. Nucleic Acids Res. 37, 2584-2595.
94. Xu S., Linher-Melville K., Yang B.B., Wu D. and Li J. (2011). Microrna378 (miR-378) regulates ovarian estradiol production by targeting aromatase. Endocrinology 152, 3941-3951.
95. Yang W., Lee D.Y. and Ben-David Y. (2011). The roles of microRNAs in tumorigenesis and angiogenesis. Int J. Physiol. Pathophysiol. Pharmacol. 3, 140-155.
96. Ye W., Lv Q., Wong C.K., Hu S., Fu C., Hua Z., Cai G., Li G., Yang B.B. and Zhang Y. (2008). The effect of central loops in miRNA:Mre duplexes on the efficiency of miRNA-mediated gene regulation. PLoS One 3, e1719.
97. Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., Huang Y., Hu X., Su F., Lieberman J. and Song E. (2007). Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131, 1109-1123.
98. Zhang X., Chen J., Radcliffe T., Lebrun D.P., Tron V.A. and Feilotter H. (2008a). An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffin-embedded human tissue samples. J. Mol. Diagn. 10, 513-519.
99. Zhang Z., Li Z., Gao C., Chen P., Chen J., Liu W., Xiao S. and Lu H. (2008b). Mir-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab. Invest. 88, 1358-1366.
100. Zhu S., Si M.L., Wu H. and Mo Y.Y. (2007). Microrna-21 targets the tumor suppressor gene tropomyosin 1 (tpm1). J. Biol. Chem. 282, 14328-14336.
101. Zhu S., Wu H., Wu F., Nie D., Sheng S. and Mo Y.Y. (2008). Microrna-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 18, 350-359.